Both in Pharmaceuticals
Contineum Therapeutics vs Rezolute, Inc. Common Stock (NV)
Over the past year CTNM returned −7.9% and RZLT returned −55.8%; their daily moves had a correlation of 0.03.
CTNM −7.9% RZLT −55.8%Growth of $1, one year, split-adjusted
| Metric | CTNM | RZLT |
|---|---|---|
| Price | $9.81 | $4.02 |
| Market cap | $369.1M | $388.8M |
| Today | +2.62% | +3.61% |
| 1 month | −22.9% | −7.2% |
| 6 months | −31.8% | +22.2% |
| Year to date | −14.2% | +70.3% |
| 1 year | −10.9% | −56.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $236.6M | $107.8M |
| Dividend yield | — | — |
| Volatility (60d) | 117.7% | 60.2% |
| Short % of float | 13.1% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).